eXoZymes, Inc.

eXoZymes, Inc. is a development-stage biotechnology company. It focuses on developing enzyme modules and cell-free exozyme biosolutions for synthetic biology manufacturing. The company was formerly known as Invizyne Technologies, Inc. and changed its name to eXoZymes, Inc. in February 2025. Incorporated in 2014, it is headquartered in Monrovia, California.

EXOZ▼

eXoZymes reports second quarter 2026 results

eXoZymes reported its second quarter 2026 results. Operating expenses for the second quarter of 2026 were $2.95 million, compared with $2.55 million for the same period in 2025. Net loss was $2.88 million for the quarter and $5.25 million for the six months ended June 30, 2026. The Company ended the quarter with $5.65 million in cash and cash equivalents, which the Company expects will support operations through the end of 2026.

EXOZ ▼

Seeking Alpha·29dRead more →